沈阳红药品牌怎么样 申请店铺

我要投票 沈阳红药在医疗器械行业中的票数:320 更新时间:2025-06-08
沈阳红药是哪个国家的品牌?「沈阳红药」是 沈阳红药集团股份有限公司 旗下著名品牌。该品牌发源于辽宁省沈阳市,由创始人赵董在1957年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力沈阳红药品牌出海!将品牌入驻外推网,定制沈阳红药品牌推广信息,可以显著提高沈阳红药产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

沈阳红药怎么样

沈阳红药集团股份有限公司,始建于1957年,老百姓的家庭常备用药,较早生产红药片,跌打损伤用药领域知名企业


沈阳红药集团股份有限公司是台港澳合资企业。成立于1957年,已有50多年的辉煌历史。沈阳红药人不辱使命,审时度势、高屋建瓴,抓住历史机遇,2008年开始了资产重组和品牌升级战略的实施。

在过去50年的发展历程中,历代沈阳红药人始终恪守“造就国药精品,福泽人类健康”的企业宗旨;秉承“良心良药”的经营理念;严格按照国家GMP标准进行生产管理和质量管理,同时专注于和商业伙伴建立同生共赢的合作关系,使沈阳红药的金字招牌时刻熠熠生辉。公司目前能够生产十余个剂型,一百五十多个品种,已有五十五个品种进入国家医保目录,七十多个品种进入国家OTC产品目录。

1972年,沈阳红药制药根据民间流传已久的经典药方,利用现代科学技术,研制生产出红药片。经过几十年的持续开发和不断创新,沈阳红药已发展为涵盖口服、外用两大给药方式,包含沈阳红药片、沈阳红药胶囊、红药贴膏、红药气雾剂、红药片等多种剂型的家族系列产品,成为老百姓的家庭常备用药。公司的其它产品:如乳癖消片、追风透骨丸、海珠喘息定片、冠心苏合丸、牛黄降压丸等,均以其独特的疗效、优良的品质、合理的价格而倍受广大医务工作者和患者的青睐。

公司注重产品研发和质量管理体系建设,以上海中医药大学和中国药科大学为依托,与沈阳药科大学、辽宁中医药大学合作,形成科研临床战略联盟,成立博士后科研工作站,保障产品研发的支撑。沈阳红药将质量放在首位,从源头抓起,在安徽亳州建立了亳州饮片加工厂,并建立督察体系,保障原料无污染,无掺假。此外,在辽宁铁岭市建立了占地几百亩的沈阳红药GAP基地。对消费者和社会履行“良心良药”的承诺。

沈阳红药公司市场营销,在以辽宁本省为主体的东北市场,有着较高的市场占有率和市场份额,同时有稳定的分销渠道、广泛的市场终端,在消费者中有着较好认知度。企业不断扩大外埠市场份额,确定了夯实东北,逐鹿中原、辐射全国的营销战略和布局。至2010年底,沈阳红药集团股份有限公司的年销售收入将突破3个亿,实现利税8千万元。在初步完成全国市场覆盖的同时,沈阳红药制药已经将产品远销美洲、东南亚地区,开始了国际市场的筹谋和布局。

为了进一步提升“沈阳红药”的品牌影响力,加速品牌升级。公司2007年底启动了整合营销的战略,在2008年初与国内营销策划机构联手,利用省级卫视和各种传播媒介、公关活动及全国网络、报刊等行业媒介,强化品牌传播,结合终端推广升级,多角度的向消费者隆重推出沈阳红药家族系列产品。通过实施沈阳红药家族的“蓝海策略”,扩大品牌知名度。不断加载品牌内涵,传承企业文化,通过红色和氏璧和沈阳红药这一鲜明的品牌识别符号,表达沈阳红药致礼患者、回馈社会的责任和义务,诠释了企业团结协作、繁荣昌盛的寓意。

沈阳红药公司注重树立热衷公益、回报社会的品牌价值观,在“5.12”汶川大地震的时候,慷慨解囊,为灾区捐赠价值100万元的药品,帮助灾区群众疗伤止痛,同时,企业员工自发捐款捐物,为灾区群众分忧解难。在第十一届全运会召开之际,沈阳红药向组委会无偿捐赠药品和款项,用于参与场馆建设的工作人员及参会运动员出现跌打损伤症状的治疗。2010年4月,在青海玉树发生灾情之后,沈阳红药公司又委托沈阳市红十字会向玉树灾区捐赠价值100万元的沈阳红药家族系列药品,同时在世界红十字纪念日5.8日活动中为玉树、汶川、沈阳三地地震孤儿捐赠爱心雨伞。在2013年4月四川雅安发生7.0级地震之后,沈阳红药在采取了紧急措施,通过沈阳市红十字会向四川雅安地震灾区捐赠价值100万元的赈灾药品,并决定迅速调拨赈灾药品发往灾区,为灾区人民早日康复、重建家园、度过难关,贡献一份力量。


Shenyang Hongyao Group Co., Ltd., founded in 1957, is a well-known enterprise in the field of injury medicine. It is a joint venture between Taiwan, Hong Kong and Macao. Founded in 1957, it has a glorious history of more than 50 years. Shenyang Hongyao people have met their mission, judged the situation, and grasped the historical opportunity. In 2008, they began to implement the strategy of asset restructuring and brand upgrading. In the past 50 years of development, all generations of Shenyang Hongyao people have always adhered to the enterprise tenet of "creating excellent national medicine and benefiting human health"; adhered to the business philosophy of "good conscience medicine"; carried out production management and quality management in strict accordance with the national GMP standards, and focused on building a win-win cooperative relationship with business partners, so that the golden brand of Shenyang Hongyao is always shining Hui. At present, the company can produce more than ten dosage forms and more than 150 varieties. Fifty five varieties have entered the national medical insurance catalog and more than seventy varieties have entered the national OTC product catalog. In 1972, Shenyang Hongyao Pharmaceutical Co., Ltd. developed and produced Hongyao tablets by using modern science and technology according to the classic prescriptions that have been popular among the people for a long time. After decades of continuous development and innovation, Shenyang Hongyao has developed into a family series of products covering two major ways of oral and external administration, including Shenyang Hongyao tablet, Shenyang Hongyao capsule, Hongyao paste, Hongyao aerosol, Hongyao tablet and other dosage forms, which has become a common household drug for the common people. Other products of the company, such as Rupixiao tablet, zhuofengtougu pill, Haizhu panting tablet, Guanxinsuhe pill, Niuhuang Jiangya pill, etc., are favored by the majority of medical workers and patients with their unique curative effect, excellent quality and reasonable price. The company pays attention to product R & D and quality management system construction. Relying on Shanghai University of traditional Chinese medicine and China Pharmaceutical University, the company cooperates with Shenyang Pharmaceutical University and Liaoning University of traditional Chinese medicine to form a scientific research and clinical strategic alliance, establish a postdoctoral research workstation, and guarantee the support of product R & D. Shenyang Hongyao put the quality first. Starting from the source, it established Bozhou decoction pieces processing plant in Bozhou, Anhui Province, and established an inspection system to ensure that the raw materials are free of pollution and adulteration. In addition, Shenyang Hongyao GAP base covering several hundred mu has been established in Tieling City, Liaoning Province. Fulfill the commitment of "good conscience medicine" to consumers and society. Shenyang Hongyao company has a high market share and market share in the Northeast market with Liaoning Province as the main body. Meanwhile, it has a stable distribution channel, a wide range of market terminals and a good awareness among consumers. The enterprise has continuously expanded the market share of foreign ports, determined the marketing strategy and layout of consolidating the northeast, chasing the Central Plains and radiating the whole country. By the end of 2010, the annual sales revenue of Shenyang Hongyao Group Co., Ltd. will exceed 300 million yuan and realize 80 million yuan of profit and tax. At the same time of the initial completion of the national market coverage, Shenyang Hongyao pharmaceutical has exported its products to the Americas and Southeast Asia, and started the planning and layout of the international market. In order to further enhance the brand influence of "Shenyang Hongyao" and accelerate the brand upgrading. At the end of 2007, the company launched the integrated marketing strategy. At the beginning of 2008, it joined hands with the domestic marketing planning agencies to use provincial satellite TV, various media, public relations activities, national networks, newspapers and other industry media, strengthen brand communication, and combine with terminal promotion and upgrading to launch the red drug family products of Shenyang grandly to consumers from multiple perspectives. Through the implementation of "Blue Ocean Strategy" of Shenyang Hongyao family, to expand brand awareness. Through the distinctive brand identification symbols of red heshibi and Shenyang Hongyao, we can express the responsibilities and obligations of Shenyang Hongyao in giving gifts to patients and giving back to the society, and interpret the meaning of unity, cooperation and prosperity of enterprises. Shenyang Hongyao company attaches great importance to establishing the brand values of loving the public welfare and repaying the society. During the "5.12" Wenchuan earthquake, it generously donated 1 million yuan worth of drugs to the disaster area to help the people in the disaster area heal and relieve pain. At the same time, the employees of the company spontaneously donate materials to help the people in the disaster area share their worries and solve their difficulties. On the occasion of the 11th National Games, Shenyang Hongyao donated drugs and money to the organizing committee free of charge for the treatment of injuries caused by falls of staff and athletes participating in the venue construction. In April 2010, after the disaster in Yushu, Qinghai Province, Shenyang Hongyao company entrusted Shenyang Red Cross Society to donate 1 million yuan of Shenyang Hongyao family drugs to Yushu disaster area, and donated love umbrellas to Yushu, Wenchuan and Shenyang earthquake orphans during the World Red Cross Memorial Day 5.8. After the 7.0-magnitude earthquake in Ya'an, Sichuan Province in April 2013, Shenyang Hongyao took emergency measures to donate 1 million yuan worth of disaster relief drugs to the earthquake stricken areas of Ya'an, Sichuan Province through the Shenyang Red Cross Society, and decided to quickly allocate disaster relief drugs to the disaster stricken areas, so as to make a contribution to the early recovery, reconstruction of homes, and overcoming difficulties of the people in the disaster areas.

本文链接: https://brand.waitui.com/6f4f6436f.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

洪灏辞任华福国际CEO

记者获悉,知名策略师洪灏日前已辞任华福国际(香港)金融控股有限公司CEO一职,目前担任其本人公司Lotus Asset Management的管理合伙人兼首席投资官。华福国际在回应记者采访时表示,公司尊重洪灏基于个人职业规划作出的决定,今后将与洪灏在相关业务领域继续保持合作。目前华福国际各项业务进展顺利,核心团队稳定,未来将持续推进国际化战略。(每经网)

47分钟前

国产具身大模型首次获得汽车制造全场景验证

6月7日,东风柳州汽车有限公司与智平方(深圳)科技有限公司在深圳正式签署战略合作协议,双方将共同探索具身大模型在汽车制造全方位场景的首次深度应用。根据协议,搭载智平方全域全身VLA(GOVLA)大模型的通用智能机器人AlphaBot 2(爱宝)将首次进驻东风柳汽汽车工厂,在上下料、拖拽料车、贴挡风玻璃标签、收纳保护布等多个场景执行智能化作业。这标志着国产具身大模型首次获得汽车制造全场景验证。(新浪财经)

47分钟前

微软将对人工智能模型的“安全性”进行排名

微软将对人工智能模型的“安全性”进行排名。(新浪财经)

47分钟前

鸿蒙电脑构建了从芯片到系统的自主体系

赛迪智库信息化与软件产业研究所信息技术研究室副主任王洁琼分析,鸿蒙PC(个人电脑)构建了从芯片到系统的自主体系,一定程度上打破了Windows、macOS等国外产品的长期商业垄断,有望实现国产操作系统在个人电脑消费市场的规模化商用。目前,鸿蒙操作系统的主要市场是在手机、平板、汽车等移动终端,推出鸿蒙PC将延续其移动端的用户优势及产品能力,对PC端大众消费市场格局有较大影响。(经济日报)

47分钟前

Meta 首席技术官:今年是增强与虚拟现实业务的“关键之年”

Meta 首席技术官 Andrew “Boz” Bosworth 近期在接受采访时表示,2025 年可能是 Meta 旗下现实实验室(Reality Labs)的“伟大之年(the year of greatness)”,也可能是元宇宙沦为“传奇失败案例”的一年。而如今,Bosworth 看起来更倾向于相信其有实现伟大的潜力,但最终的决定权仍在市场手中。(IT之家)

47分钟前

本页详细列出关于沈阳红药的品牌信息,含品牌所属公司介绍,沈阳红药所处行业的品牌地位及优势。
咨询